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During development of the mammalian nervous system, neural stem cells generate neurons first and
glia second, thereby allowing the initial establishment of neural circuitry, and subsequent matching of
glial numbers and position to that circuitry. Here, we have reviewed work addressing the mechanisms
underlying this timed cell genesis, with a particular focus on the developing cortex. These studies
have defined an intriguing interplay between intrinsic epigenetic status, transcription factors, and
environmental cues, all of which work together to establish this fascinating and complex biological
timing mechanism.During development of the vertebrate central nervous sys-
tem, neurons are generated first, and glial cells second
(Bayer and Altman, 1991), while in lower organisms such
as flies, these two cell types appear coincidentally. This
timed cell genesis in vertebrates makes good biological
sense, since the bare bones of neuronal circuitry are ini-
tially established, and then the numbers and positions of
glia are matched to that circuitry. However, while the un-
derlying rationale is apparent, until recently the responsi-
ble mechanisms were less so. In this regard, studies
addressing various aspects of nervous system develop-
ment have now converged to provide us with insights
into this issue. Here, we will review studies addressing
this issue in the developing mammalian cortex. These
studies have defined an intriguing interplay between intrin-
sic developmental programs and environmental cues,
thereby providing us with a coherent overview of what
has turned out to be a fascinating, novel, and perhaps
not surprisingly, complex biological timer.
Much of the work examining the neurogenic-to-glio-
genic switch has focused upon the developing mamma-
lian neocortex for several major reasons. First, genesis
of different cortical cell populations is temporally segre-
gated; in rodents, neurons are generated from embryonic
day 12 (E12) to E18, astrocytes appear at around E18, with
their numbers peaking in the neonatal period, and differ-
entiated oligodendrocytes are first seen postnatally (Fig-
ure 1) (Bayer and Altman, 1991). Even neurons of the dif-
ferent cortical layers are sequentially generated in an
‘‘inside-out’’ fashion, with the latest-born neurons being
the most superficial. Second, this timed genesis also oc-
curs in culture. Cultured primary E10–E12 cortical precur-
sors (a term used here to encompass both cortical stem
cells and their more biased progeny) generate only neu-
rons for the first few days, followed by the sequential gen-
esis of astrocytes and oligodendrocytes. Remarkably,Sally Temple and her colleagues demonstrated that this
timed genesis of neurons versus glia and even early versus
late-born neurons occurred within clones of single precur-
sor cells (Qian et al., 2000; Shen et al., 2006). Third, retro-
viral lineage tracing studies demonstrated that, in vivo,
single precursors contributed to both the neuronal and
glial lineages, and that the repertoire of cell types gener-
ated by individual precursors changed over development
(Walsh and Reid, 1995). For example, when the very early
cortex was transduced (McCarthy et al., 2001), many pre-
cursorsmade only neurons, somemade both neurons and
glia, and some, surprisingly, made only glia, potentially be-
cause they waited until later time points to differentiate.
Thus, multipotent cortical precursors change their behav-
ior over time in vivo, generating first neurons and then glia,
and the underlying timer mechanism(s) is maintained in
clones of isolated precursor cells.
What then, have we learned about the neurogenic-to-
gliogenic switch? Tremendous progress has been made
in this area, largely by addressing the following specific
questions. What limits precursors from making glia during
the neurogenic period? What is the signal that directs pre-
cursors to start making glia at the expense of neurons, and
does the same signal inhibit the genesis of neurons during
the gliogenic period? Are precursor cells equally compe-
tent to generate neurons and glia at all developmental
time points? If not, are the underlying intrinsic changes re-
versible or are they hardwired? Do perturbations in these
mechanisms impact on developmental disorders or in-
jury/degenerative responses in the mature nervous sys-
tem? Recent studies addressing these questions support
two major conclusions. First, precursor cells change in
terms of their competence over time, being more biased
to make neurons early, and glia late. Second, the extrinsic
environment that a precursor finds itself in is a key deter-
minant of its differentiation. For example, embryonicNeuron 54, May 3, 2007 ª2007 Elsevier Inc. 357
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ReviewFigure 1. The Neurogenic-to-Gliogenic Switch in the Developing Neocortex
During development of the vertebrate central nervous system, neurons are generated first and glia second. Within the developing rodent neocortex,
multipotent precursors generate neurons from approximately E12 to E18, and then the newly born cortical neurons secrete CT-1, which acts in con-
cert with other gliogenic environmental cues such as BMP2 and the Notch ligands to induce the onset of astrocyte formation at approximately E18.cortical precursors make neurons when cultured on em-
bryonic cortical slices, but astrocytes when cultured on
postnatal cortical slices (Morrow et al., 2001). Thus, the
neurogenic-to-gliogenic switch depends upon the inter-
play between developmental biases and potent environ-
mental signals, the nature of which will be described
below.
The Trouble with Studying Neural Precursors.
Before reviewing the studies that have contributed to our
understanding of the neurogenic-to-gliogenic switch, it
is important to consider a number of experimental limita-
tions. Astrocytes are the first glia to appear in the neocor-
tex, and most studies have thus focused upon the switch
from making neurons to astrocytes. However, many early
studies utilized only GFAP, a late astrocyte protein, as
a surrogate for astrogenesis due a paucity of appropriate
markers. This approach has two caveats. First, GFAP ex-
pression does not distinguish astrogenesis from terminal
astrocyte differentiation. Second, many embryonic and
adult neural precursors express proteins previously
thought to be astrocyte specific, including GFAP. For ex-
ample, embryonic radial ‘‘glial’’ cells were recently shown
to be neural precursors that generate both neurons and
astrocytes (Gotz and Barde, 2005). These radial precur-
sors express astrocyte markers such as BLBP, RC2,
and outside of the cortex, GFAP. Thus, in response to
these considerations, recent studies have examined addi-358 Neuron 54, May 3, 2007 ª2007 Elsevier Inc.tional astrocyte markers/genes and, in the large majority
of cases, have confirmed the earlier conclusions.
A second experimental consideration is the lack of
markers that distinguish neural stem cells from their
more biased progeny. The neuroepithelium of the devel-
oping cortex contains multiple populations of precursors,
including true multipotent stem cells that self-renew.
Clonal analysis in culture also indicates the existence of
unipotent and bipotent precursors, including a bipotent
glial precursor. However, we are not yet able to prospec-
tively isolate these different precursor populations or to
definitively distinguish them in vivo, meaning that most
studies manipulate multiple precursor types simulta-
neously. Complicating the analysis further are findings in-
dicating that the progression from amultipotent precursor
to a terminally differentiated cell type may not be a one-
way street. For example, in the male germ cell lineage,
a subset of transit-amplifying cells can move into vacated
stem cell niches and start behaving like stem cells with re-
gard to self-renewal (Nakagawa et al., 2007). Similarly, bi-
ased oligodendrocyte precursors will dedifferentiate to
become multipotent neural stem cells in culture (Kondo
and Raff, 2000). Thus, the precise point at which a given
signal regulates the transition from a multipotent stem
cell to a terminally differentiated neuron or glial cell can
be difficult to ascertain. Nonetheless, the studies reviewed
here have established a clear framework for understand-
ing the neurogenic to gliogenic switch, and as we develop
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even more sophisticated and complete view of this
complex transition.
A Central Role for a Neuron-Driven
Cardiotrophin-1-gp130-JAK-STAT
Pathway in the Initiation of Gliogenesis
The aforementioned study byMorrow et al. (2001) demon-
strated that neurogenic cortical precursors became glio-
genic if placed in a postnatal cortical environment. So
what is the extrinsic cue that induces the gliogenic switch?
The answer to this came from two coincident lines of
study, both of which implicated cytokines of the IL-6
family. This particular subfamily of cytokines includes cili-
ary neurotrophic factor (CNTF), leukemia inhibitor factor
(LIF), and cardiotrophin-1 (CT-1), all of which require and
induce heterodimerization of two signal-transducing
b subunits, the coreceptors LIFRb and gp130. These re-
ceptors activate a number of signaling cascades, includ-
ing the JAK-STAT pathway, where the JAKs are kinases
that associate with and are activated by gp130, and the
STATs are transcription factors that are phosphorylated
and activated by the JAKs (reviewed in Ernst and Jenkins,
2004). In one set of studies, mice lacking either LIFRb or
gp130 were shown to have profound deficits in astrocyte
formation (Ware et al., 1995; Koblar et al., 1998; Naka-
shima et al., 1999a). This phenotype was directly due
to perturbations in astrogenesis, since (1) cultured
gp130/ or lifrb/ neural precursors were deficient in as-
trocyte formation (Koblar et al., 1998; Nakashima et al.,
1999a), and (2) an acute knockdown of gp130 in cortical
precursors caused a decrease in the number of precur-
sors that generated early astrocytes in vitro, and a cell-
autonomous decrease in astrocyte formation in vivo
(Barnabe´-Heider et al., 2005). The second group of stud-
ies demonstrated that CNTF and LIF were sufficient to in-
duce astrogenesis (Johe et al., 1996; Bonni et al., 1997;
Nakashima et al., 1999b), and that this action required
LIFRb and gp130 (Bonni et al., 1997; Nakashima et al.,
1999a, 1999b). A subsequent study then demonstrated
that ectopic expression of CNTF induced premature corti-
cal astrocyte formation in vivo (Barnabe´-Heider et al.,
2005), indicating that at least a subset of cortical precur-
sors were competent to generate astrocytes during the
neurogenic period, and confirming that exposure to glio-
genic cytokines could regulate the timing of astrogenesis.
These and subsequent studies then addressed the un-
derlying mechanisms and demonstrated that cytokine-
mediated gliogenesis involved activation of the JAK-
STAT pathway. In particular, CNTF, LIF, CT-1, and other
members of this family activated the JAKs and STAT1
and STAT3 in neural precursors, and the inhibition of
STAT3 signaling abolished their ability to regulate astro-
cyte formation either in culture (Bonni et al., 1997; Rajan
and McKay, 1998) or in vivo (Barnabe´-Heider et al.,
2005). Important insights into this activity came with the
demonstration that the STATs caused direct transcrip-
tional activation of two astrocytic genes, gfap ands100b, via STAT binding sites within their promoters
(Bonni et al., 1997; Nakashima et al., 1999b; Namihira
et al., 2004). This transactivation of glial genes required in-
teractions between STATs and p300/CBP, two related
coactivators that associate with a wide variety of tran-
scription factors to promote transcription, in part by acet-
ylating histones and inducing an active chromatin confor-
mation (Kalkhoven, 2004). Moreover, overexpression of
p300 was sufficient to enhance cytokine-mediated gfap
expression, implying that coactivator levels might be lim-
iting for gliogenesis (Nakashima et al., 1999b). Interest-
ingly, the neurogenic bHLH ngn1 also bound to p300/
CBP, and this interaction inhibited p300/CBP from associ-
ating with STAT3, thereby providing a way in which neuro-
genic bHLHs could directly suppress cytokine-mediated
gliogenesis (discussed in more detail below) (Sun et al.,
2001). Together, these studies provided compelling evi-
dence that ligand binding to the LIFRb and gp130 core-
ceptors was necessary for astrogenesis in the developing
neocortex. In addition, since astrocytes are profoundly
decreased throughout the brain and spinal cord of mice
genetically deficient in these receptors (Ware et al.,
1995; Nakashima et al., 1999a), then this suggests that
theymaywell play a similar role throughout the developing
CNS.
But what was the relevant LIFRb/gp130 ligand? The first
clue came from studies showing that the switch frommak-
ing neurons to astrocytes in culture required signaling via
gp130 and STAT3, implying that cortical precursors and/
or their progeny make a gliogenic cytokine(s) (Nakashima
et al., 1999a; Barnabe´-Heider et al., 2005). The relevant
cytokine was, however, unlikely to be CNTF or LIF (the
two most widely used exogenous ligands), since neither
is expressed until postnatal life (Stockli et al., 1991; Patter-
son and Fann, 1992), and mice lacking these genes dem-
onstrated no (in the case of cntf) or very modest (in the
case of lif) deficits in astrocyte number (Masu et al.,
1993; Bugga et al., 1998). A recent study then demon-
strated that CT-1 was a key gliogenic ligand. Specifically,
Barnabe´-Heider et al. (2005) showed that CT-1 was ex-
pressed in newly born cortical neurons, that ablation of
this neuron-derived CT-1 completely blocked the neuro-
genic to gliogenic transition in cultured cortical precur-
sors, and that ct-1/ mice had 50%–70% deficits in the
level of cortical astrogenesis. Thus, a major extrinsic
mechanism for regulating the onset of gliogenesis appar-
ently involves a feedback loop, wherein the first-born cell
type, neurons, produces CT-1, which then instructs the
parent cortical precursors to generate a second cell
type, astrocytes (Figure 1).
BMPs and Notch Activation Instructively
Promote Astrogenesis in Collaboration
with the JAK-STAT Pathway
Twoother important developmental signals, theBMPsand
Notch, instructively promote astrogenesis, collaborating
at least in part with the gliogenic JAK-STAT pathway.
The relevant BMP family members are BMP2 and BMP4,
Neuron
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At least three different environmental signals, CT-1, BMPs, and Notch ligands, converge to regulate the appropriate timing of gliogenesis. Foremost
among these is the gliogenic cytokine CT-1, which binds to the gp130 and LIFRb coreceptors, which then signal via the JAKs to phosphorylate and
activate the STAT3 transcription factors. STAT3 then forms a complex with the Smads, which are downstream of activated BMP receptors, and the
coactivator p300/CBP. This complex binds to the promoter of glial genes such as gfap to directly promote transcription. The gliogenic cytokine CT-1
also causes translocation of the repressor protein NCoR from the nucleus to the cytoplasm. At the same time, Notch activation causes its downstream
effector, the RBP-Jk transcription factor, to bind and transactivate the gfap promoter. Finally, a third key proastrocytic transcription factor, NF1, also
binds to the gfap promoter. It is the coordinated actions of these different effector pathways that determine the timing and number of astrocytes that
are ultimately formed.which bind to their heterotrimeric serine/threonine kinase
receptors to signal largely via activation of thedownstream
transcription factors, Smads 1, 5, and 8 (reviewed in Chen
et al., 2004). These growth factors havemultiple effects on
neural cell genesis. For example, in cortical precursors
BMP2 enhances neurogenesis during the neurogenic pe-
riod (Li et al., 1998;Mabie et al., 1999) and instructively pro-
motes astrocyte formation during the gliogenic period
(Gross et al., 1996; Gomes et al., 2003). Insights into the
underlying gliogenic mechanism came from a key study
showing that, in precursors exposed togliogenic cytokines
and BMP2, Smad1 forms a transcriptional complex with
activated STAT3 and p300/CBP (Nakashima et al.,
1999b). Interestingly, binding of Smad1 to p300/CBP is in-
dependent of interactions between p300/CBP and the
STATs or ngn1 (Sun et al., 2001), providing a potential mo-
lecular explanation for the dual actions of BMP2. In this
model, during the gliogenic period, when ngn1 levels are
low, exposure to BMP2 and gliogenic cytokines causes
formation of a Smad:p300/CBP:STAT complex that trans-
activates gliogenic genes. Under these conditions, BMPs
also cause expression of inhibitory HLHs such as Id1 (Na-
kashima et al., 2001) that can antagonize any neurogenic
bHLHs expressed in the same precursors, thereby ensur-360 Neuron 54, May 3, 2007 ª2007 Elsevier Inc.ing that precursorsmake glia and not neurons (Figure 2). In
contrast, during the neurogenic period, precursors ex-
press high levels of bHLHs like ngn1, and BMP2 exposure
then causes formation of a Smad:p300/CBP:ngn1 com-
plex that inhibits gliogenesis by sequestering p300/CBP
from the STATs, and that can potentially participate in
transactivation of neuronal genes (Sun et al., 2001) (Fig-
ure 3). However, while this competitive model is attractive,
we still don’t knowhow important BMPsare for gliogenesis
in vivo, sincemice carrying knockouts ofmany of the path-
way components are embryonic lethal (Chen et al., 2004),
and conditional inactivation of bmpr1a and/or bmpr1b in
the nervous systemhas only been reported to perturb neu-
ronal development (Wine-Lee et al., 2004; Qin et al., 2006).
Like the BMPs, the Notch pathway has been the subject
of intense investigation (reviewed in Kadesch, 2004; Louvi
and Artavanis-Tsakonas, 2006). In very basic terms,
Notch, upon binding to its ligands, is activated and
cleaved, and the Notch intracellular domain (NICD) then
translocates to the nucleus, where it interacts with RBP-
Jk (also termed CSL, CBF1, and suppressor of hairless)
to form a transcriptionally active complex. RBP-Jk directly
regulates transcriptional events, including transcription of
the prototypic Notch effectors, the hes inhibitory bhlh
Neuron
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during the Neurogenic Period
Multiple mechanisms determine the timing and numbers of neurons that are generated during the neurogenic period. Foremost among these are the
neurogenic bHLH proteins, which directly promote transcription of neuronal genes and at the same time inhibit gliogenesis by sequestering the p300/
CBP cofactors. During the neurogenic period, BMPs like BMP2 also signal via their cognate receptors to promote neurogenesis, at least partially by
interactions between the activated Smad transcription factors and p300/CBP. In addition, receptor tyrosine kinase receptors bind to growth factors
such as the neurotrophins and PDGF and directly activate aMEK-ERK-Rsk pathway that induces phosphorylation of the C/EBP family of transcription
factors. The C/EBPs then bind directly to the promoters of neuronal genes, such as that encoding Ta1 a-tubulin, and drive transcription of those
genes. At the same time, gliogenesis is repressed by both intrinsic and extrinsic mechanisms during the neurogenic period. In particular, glial genes
such as the gfap and s100b genes are methylated, and the MeCP2 protein binds to these methylated CpGs and promotes formation of an inactive
chromatin conformation. A second repressive mechanism involves neuregulin binding to the ErbB4 receptor, which causes translocation of the NCoR
repressor protein to the nucleus, where it complexes with the Notch effector RBP-Jk and binds directly to the gfap promoter. Finally, pathways such
as the MEK-ERK-C/EBP pathway that promote neurogenesis at the same time inhibit gliogenesis by as yet undefined mechanisms.genes. With specific regard to mammalian neural precur-
sors, activation of the Notch pathway has two distinct and
temporally dissociable effects. During the neurogenic pe-
riod, Notch signaling inhibits neurogenesis and promotes
the maintenance of neural precursors such as radial glia
(Gaiano et al., 2000). This important role is particularly ev-
ident in animals lacking components of the Notch signal-
ing pathway, all of which demonstrate depletion of neural
precursors and premature neurogenesis (reviewed in
Yoon and Gaiano, 2005). Notch also instructively pro-
motes gliogenesis, as first demonstrated in the peripheral
nervous system and retina (Morrison et al., 2000; Furu-
kawa et al., 2000). Similar findings were then reported
for embryonic telencephalic precursors (Chambers et al.,
2001; Grandbarbe et al., 2003) and adult hippocampal
precursors (Tanigaki et al., 2001), suggesting that this is
a general Notch function.
How does Notch promote gliogenesis? Evidence indi-
cates that it may do so via both RBP-Jk and the Hes
bHLH transcription factors. With regard to RBP-Jk, this
transcription factor binds directly to the gfap promoterand promotes transcription, but only when the JAK-
STAT pathway is coincidentally activated (Ge et al.,
2002). When the JAK-STAT pathway is not activated,
RBP-Jk instead binds to a repressive cofactor protein,
NCoR (Hermanson et al., 2002), which functions to re-
press gliogenic genes (described in detail below). As for
the Hes proteins, Hes1 and the Hes-related proteins
Hesr1 and Hesr2 all inhibit neurogenesis during the neuro-
genic period and, when ectopically expressed during the
gliogenic period, promote astrogenesis (Sakamoto et al.,
2003; Wu et al., 2003; Furukawa et al., 2000; Kageyama
et al., 2005). The Hes proteins apparently mediate these
effects by inhibiting neurogenic bHLHs (which promote
neurogenesis and repress gliogenesis, as discussed in
detail below), and by promoting activation of the JAK-
STAT pathway (Kamakura et al., 2004). These various
studies provide evidence that RBP-Jk and Hes1 require
coincident activation of the JAK-STAT pathway for their
gliogenic actions, thereby suggesting that, like BMP2, en-
vironmental cytokines like CT-1 are necessary for Notch to
become gliogenic. However, the in vivo importance ofNeuron 54, May 3, 2007 ª2007 Elsevier Inc. 361
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is still unclear, sincemice genetically deficient in the Notch
pathway exhibit early embryonic lethality, and a condi-
tional knockout of the Notch receptors in the developing
nervous system has not yet been reported.
Silence Is Golden: Gliogenesis Is Repressed
during Neurogenesis by Intrinsic Mechanisms
While these studies demonstrate the importance of extrin-
sic positive signals for driving gliogenesis, they do not in-
dicate how gliogenesis is silenced during the neurogenic
period. This is a key issue, since at least two gliogenic cy-
tokines, neuropoietin (Derouet et al., 2004) and cardiotro-
phin-like cytokine (Uemura et al., 2002), are expressed in
the early embryonic cortex and yet there is no gliogenesis.
However, insights into this issue derive from recent work
showing that precursor cells change in their competence
to respond to gliogenic cytokines over development. For
example, a comparison of E10/11 and E14 cortical precur-
sors showed that the younger precursors required pro-
longed culturing before they made astrocytes and re-
sponded poorly to cytokines with regard to JAK-STAT
pathway activation and gfap transactivation (He et al.,
2005). Thus, precursors change intrinsically over time,
and these intrinsic changes are important for the neuro-
genic/gliogenic timing mechanism.
What are these intrinsic repressive mechanisms? One
mechanism involves epigenetic silencing of genes that
are necessary for astrocyte formation via DNAmethylation
and/or chromatin modifications. The first demonstration
of this involved the finding that the STAT3 binding site in
the gfap promoter was preferentially methylated in neuro-
genic versus gliogenic cortical precursors, and that this
methylation inhibited STAT3 association and gfap tran-
scription (Takizawa et al., 2001). The in vivo importance
of this methylation was then demonstrated by analysis of
a conditional knockout of the DNA methyltransferase 1
(dnmt1) gene in neural precursors (Fan et al., 2005). Brains
of these mice displayed decreased numbers of neurons,
precocious astrogenesis, and aberrant upregulation of
the gfap and s100b genes, the latter of which is also meth-
ylated in early cortical precursors (Namihira et al., 2004).
Interestingly, genes in the gp130-JAK-STAT pathway
were also derepressed in dnmt/ precursors, and
STAT3 inhibition abolished the observed increase in glio-
genesis (Fan et al., 2005). A subsequent study provided
further support for the idea that methylation of genes in
the gp130-JAK-STAT pathway regulated the gliogenic
potential of cortical precursors and demonstrated that
cytokines themselves derepressed the pathway, thereby
defining a positive feedforward loop (He et al., 2005).
Thus, in early neural precursors, DNA methylation re-
presses genes encoding astrocyte-specific genes and
the gp130-JAK-STAT pathway, and this repression is
lifted as precursors develop.
A second mechanism for repressing gliogenesis during
early neural development involves the neurogenic bHLHs.
While many studies have defined a role for bHLHs like362 Neuron 54, May 3, 2007 ª2007 Elsevier Inc.ngn1, ngn2, and Mash1 in neurogenesis and neuronal dif-
ferentiation (reviewed in Bertrand et al., 2002), it has only
recently been appreciated that they also regulate gliogen-
esis. This was first shown in studies ablating or overex-
pressing these bHLHs. Mice carrying mutations in
mash1 and math3 (Tomita et al., 2000), or to a lesser
extent, mash1 and ngn2 (Nieto et al., 2001) exhibited
decreased neurogenesis, and enhanced and premature
astrogenesis. Conversely, overexpression of neurogenic
bHLHs either in vivo during the gliogenic period (Cai
et al., 2000) or in cultured precursors exposed to CNTF
(Sun et al., 2001) promoted neurogenesis at the expense
of gliogenesis. Moreover, inhibition of neurogenic bHLHs
by ectopic expression of their endogenous inhibitors, the
HLHs Id1 and Id2, inhibited neurogenesis (Toma et al.,
2000; Cai et al., 2000) and promoted gliogenesis (Cai
et al., 2000). Thus, neurogenic bHLHs bias precursors to
make neurons and at the same time inhibit cytokine-medi-
ated astrocyte formation. Interestingly, one of the mecha-
nisms underlying the repressive gliogenic effect involves
a direct interaction between neurogenic bHLHs and the
JAK-STAT pathway; Ngn1 binds to and sequesters
CBP/p300, so that it is not available to bind to activated
STAT3, thereby inhibiting gliogenic transcription (Sun
et al., 2001). Such amechanismwould ensure that precur-
sors biased to make neurons by high levels of neurogenic
bHLHs would not be permitted to become astrocytes in
response to gliogenic cytokines.
Silence Is Golden II: Environmental Signals
Regulate Precursor Cell Competence
In addition to these intrinsic mechanisms, the gliogenic
competence of neural precursors is regulated by environ-
mental signals. One example of this involves receptor
tyrosine kinase (RTK)-mediated activation of a SHP-2-
MEK-ERK-Rsk pathway. This signaling cascade pro-
motes neurogenesis (Me´nard et al., 2002; Barnabe´-Heider
and Miller, 2003; Paquin et al., 2005; Liu et al., 2006;
Gauthier et al., 2007), at least in part by enhancing phos-
phorylation of the C/EBP family of transcription factors,
which are well known for regulating developmental cell
genesis outside of the nervous system (Lane et al., 1999;
Yamanaka et al., 1998). Phosphorylation of the C/EBPs
then promotes neurogenesis via direct transactivation of
neuronal genes such as ta1 a-tubulin (Me´nard et al.,
2002) and math2 (Uittenbogaard et al., 2007). At the
same time, this pathway utilizes several distinct mecha-
nisms to regulate the timing and extent of astrocyte forma-
tion. First, RTK-mediated activation of the protein tyrosine
phosphatase SHP-2 both enhances activation of the
MEK-ERK pathway and directly represses the gp130-
JAK-STAT pathway, thereby promoting neurogenesis
and ensuring that astrogenesis does not occur during
the neurogenic period (Gauthier et al., 2007). Second,
the C/EBPs, and their upstream activators MEK and
ERK, potently repress astrocyte formation via an as-yet-
undefined mechanism (Me´nard et al., 2002; Barnabe´-
Heider and Miller, 2003; Paquin et al., 2005; Liu et al.,
Neuron
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CBP (Mink et al., 1997), suggesting that they too might in-
hibit gliogenesis by sequestering this essential cofactor
from STAT. However, the C/EBPs both activate and re-
press transcription, suggesting that they might also act
by directly repressing gliogenic genes. Thus, at least one
growth factor-driven signaling pathway functions to inhibit
gliogenesis during the neurogenic period.
In addition to the C/EBPs and bHLHs, which directly
bias precursors to make neurons rather than glia, several
transcription factors repress gliogenic genes as part of
a mechanism to maintain precursor cells in an undifferen-
tiated state. One of these is ATF5, which inhibits cortical
precursors from differentiating into neurons or glia (Ange-
lastro et al., 2003, 2005; Mason et al., 2005). Interestingly,
at least some ATF5 family members can interact with C/
EBPs and alter their DNA binding specificity (Shuman
et al., 1997), suggesting that ATF5 might inhibit differenti-
ation by binding to and regulating C/EBPs and/or other
leucine zipper transcription factors that promote differen-
tiation. A second growth factor-regulated signaling path-
way that represses gliogenesis during the neurogenic pe-
riod involves the growth factor neuregulin-1, and the
protein N-CoR, a corepressor for multiple transcription
factors that acts by forming a complex with histone de-
acetylases. The first indication that N-CoR was important
for repressing gliogenesis came from a study showing that
gliogenesis was prematurely and robustly activated in the
n-cor/ embryonic forebrain, and that cultured n-cor/
cortical precursors did not self-renew, but instead differ-
entiated into astrocytes (Hermanson et al., 2002). Overex-
pression of N-CoR could also inhibit cytokine-mediated
gliogenesis, and this repression was dependent upon an
interaction between N-CoR and the Notch effector RBP-
Jk, which together bound to the gfap promoter. Impor-
tantly, CNTF stimulation caused translocation of N-CoR
to the cytoplasm, thereby providing a potential mecha-
nism for derepressing glial genes in response to a glio-
genic environment. More recently, Sardi et al. (2006)
demonstrated that this repressive action of N-CoR was
regulated by environmental signals; binding of neuregu-
lin-1 to its ErbB4 receptor led to cleavage and release of
the receptor intracellular domain, which formed a complex
with the adaptor protein TAB2, and N-CoR. This complex
translocated to the nucleus, where it associated with and
repressed transcription of both the gfap and s100b pro-
moters. Further evidence that neuregulin-1 suppresses
astrogenesis came from studies showing that inhibition
of the neuregulin-1 receptor ErbB2 in cortical radial glial
precursors caused them to prematurely transform into as-
trocytes (Schmid et al., 2003). Together, these findings
support a model where, during the neurogenic period, co-
incident ErbB2/ErbB4 and Notch activation cause forma-
tion of an ErbB4/TAB2/NCoR/RBP-Jk complex that di-
rectly and potently represses gliogenic genes. When
precursors are exposed to CT-1 during the gliogenic pe-
riod, N-CoR translocates to the cytoplasm, STATs are ac-
tivated, and RBP-Jk is derepressed so that it can enhanceSTAT-mediated gliogenic gene expression (Figures 2
and 3).
While these studies defined environmental cues that re-
pressed gliogenic competence during the neurogenic pe-
riod, two other growth factors, EGF and FGF2, were
shown to promote gliogenic competence. In this regard,
increased expression of EGFR in neural precursors en-
hances astrogenesis, an effect that requires at least
some JAK-STAT pathway activation (Burrows et al.,
1997; Viti et al., 2003). Moreover, EGFR is expressed
asymmetrically in neural precursors, segregating differen-
tially to daughter cells with differing fates, with high-EGFR
daughters coexpressing radial glia/astrocytic markers
(Sun et al., 2005). However, it has been difficult to define
the necessity for EGFR in regulating glial competence,
since studies of egfr/ mice indicate that this receptor
also plays a key role in astrocyte differentiation, migration,
and apoptosis (Sibilia et al., 1998; Kornblum et al., 1998;
Wagner et al., 2006). Perhaps an acute knockdown of
EGFR mRNA in neural precursors will resolve this issue.
As for FGF2, it is a potent and important mitogen for neural
precursors, and fgf2/ mice have smaller brains and de-
creased numbers of both neurons and glia (Dono et al.,
1998; Ortega et al., 1998; Vaccarino et al., 1999). In cul-
tured precursors, FGF2 does not on its own induce astro-
cyte formation, but it does promote cytokine-mediated
astrocyte formation, at least partially by promoting an ac-
tive chromatin conformation around the gfap gene (Song
and Ghosh, 2004). Interestingly, conditional ablation of
the Brg1 ATP-dependent chromatin remodeling factor in
neural precursors in vivo caused precocious neuronal dif-
ferentiation and a failure of glial differentiation (Matsumoto
et al., 2006), indicating that such environmentally regu-
lated chromatin remodeling plays a key role in regulating
all aspects of precursor cell fate determination during em-
bryogenesis. Importantly, one of the major conclusions
from this body of work is that, whilemultiple environmental
cues regulate the neurogenic to gliogenic switch, many of
them do so at least partially by converging to repress, de-
repress, or promote signaling via the gp130-JAK-STAT
pathway.
A Transcription Factor Code
for Astrocyte Formation?
The concept of a transcription factor code for cell genesis
in the mammalian nervous system arose largely out of
work demonstrating such a code in the spinal cord (Lee
and Jessell, 1999), and studies demonstrating that combi-
nations of positively acting bHLHs were essential for
neurogenesis (Bertrand et al., 2002). Subsequent work
demonstrating that oligodendrocyte development also
required positively acting bHLHs, the oligs (Lu et al.,
2002; Zhou and Anderson, 2002), supported this idea.
However, until recently no specific proastrocytic tran-
scription factor(s) had been identified, other than those
that were downstream of gliogenic signaling pathways,
such as the STATs and RBP-Jk. This situation has
changed in the past several years, with identification of
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portant of which appears to be nuclear factor-1 (NFI).
NFI-A, -B, -C, and -X are a transcription factor family
that is expressed with overlapping but unique patterns
of expression throughout the entire animal (reviewed in
Gronostajski, 2000). While NFIs activate and repress mul-
tiple genes in many tissues, the first hint that theymight be
important for astrocyte development came from work
showing that the gfap promoter contains a transcription-
ally important NFI binding site (Krohn et al., 1999; Gopalan
et al., 2006; Cebolla and Vallejo, 2006). At the same time,
analysis of embryonic nf1-a/ and nf1-b/ brains dem-
onstrated developmental disruption of the corpus cal-
losum, a large reduction in embryonic midline glia, and
5- to 10-fold decreases in GFAP mRNA and protein (das
Neves et al., 1999; Shu et al., 2003; Steele-Perkins et al.,
2005). The precise role that NF1 plays during astrocyte de-
velopment was then elucidated when it was found that
NFIA/B is necessary and sufficient for the appropriate tim-
ing and levels of astrogenesis in the developing spinal
cord (Deneen et al., 2006). Interestingly, this same study
showed that NFIA is also necessary for oligodendrocyte
fate specification, and for the repression of neurogenesis,
the latter an effect that it mediates via the Notch effector
Hes5. NFI may also inhibit neurogenesis directly, since
it can bind to and repress transcription of at least one
neuron-specific gene (Adams et al., 1995). Thus, NFI is
expressed in neural precursors immediately prior to glio-
genesis, at which point it may well collaborate with the
CT-1-mediated JAK-STAT pathway to promote astrocyte
formation, potentially by direct interactions between NFI
and the STATs, as is seen in nonneural cells (Mukhopad-
hyay et al., 2001). Moreover, NFI, like the STATs, Ngn1,
and the C/EBPs, binds to p300/CBP (Leahy et al., 1999),
and thus CBP may provide a locus for coordination of all
of these various gliogenic and neurogenic signals.
In addition to NFI, which appears to be required for as-
trogenesis throughout the developing CNS, two positively
acting astrogenic bHLHs have more circumscribed func-
tions. One of these, scl (for stem cell leukemia, also known
as Tal1), is important for cell determination in the hemato-
poietic system and was recently shown to be essential for
genesis of astrocytes within the p2 domain of the develop-
ing spinal cord (Muroyama et al., 2005). Scl was also
required for the development of multiple populations of
neurons (Bradley et al., 2006), indicating that it is not a
proastrogenic bHLH per se, but rather appears to be a
prodifferentiation factor for multiple neural cell types.
A second positively acting bHLH, neurogenin3 (ngn3),
and Sox9 have also both been reported to be important
for gliogenesis in the developing spinal cord (Lee et al.,
2003; Stolt et al., 2003). Interestingly, in both cases,
animals lacking these transcription factors displayed
deficits in both oligodendrocytes and in astrocytes,
suggesting that ngn3 and Sox9 likely act to promote
the genesis, maintenance, and/or differentiation of a bipo-
tent glial precursor, rather than to specifically promote
astrogenesis.364 Neuron 54, May 3, 2007 ª2007 Elsevier Inc.In this regard, one final issue that needs to be raised
here concerns the transcriptional mechanisms that are in-
volved in specifying astrocytes versus oligodendrocytes.
As indicated in the introduction, the onset of gliogenesis
in the cortex commences with the appearance of differen-
tiated astrocytes, and this is followed by differentiated
oligodendrocytes. However, until very recently it was
thought that cortical oligodendrocytes did not develop
from the same cortical precursors as did neurons and as-
trocytes, but that biased oligodendrocyte precursors were
instead generated in the ventral forebrain, and these mi-
grated into and populated the developing cortex. Recent
work has challenged this idea and has instead defined
a secondwave of late-differentiating oligodendrocyte pre-
cursors that derive from multipotent cortical precursors
within the dorsal cortex (Kessaris et al., 2006). Thus,
a key question for the future is how bipotent gliogenic pre-
cursors choose to make astrocytes versus oligodendro-
cytes. Interestingly, a number of recent papers indicate
that olig bHLHs, which are best known for their ability to
promote oligodendrocyte formation (Ligon et al., 2006)
while repressing astrogenesis (Zhou and Anderson,
2002), perform the latter function both by binding to
p300/CBP and sequestering it from STAT3 (Fukuda
et al., 2004), and by antagonizing the proastrocytic effects
of NFI (Deneen et al., 2006). Moreover, evidence indicates
that Hes1 both promotes astrogenesis via interactions
with the JAK-STAT pathway (Kamakura et al., 2004) and
inhibits oligodendrocyte formation by antagonizing the
olig bHLHs (Wu et al., 2003). Thus, multiple mechanisms
likely exist to regulate the choices made by gliogenic pre-
cursors, and it will be interesting to determine how these
mechanisms ensure the correct timing and numbers of
these two cell types.
What’s Next?
Together, these studies have provided us with an inte-
grated view of the neurogenic switch, with multiple extrin-
sic and intrinsic mechanisms acting in concert to repress
gliogenesis during the neurogenic period, and then to in-
duce gliogenesis when an appropriate number of neurons
has been generated (Table 1). However, many questions
remain. First, what keeps neurogenesis turned off during
the gliogenic period? We know that gliogenic precursors
can still make neurons under some conditions, since over-
expression of neurogenic bHLHs is sufficient to promote
neurogenesis in the postnatal CNS (Cai et al., 2000). We
also know that gp130-JAK-STAT signaling (Bonni et al.,
1997; Barnabe´-Heider et al., 2005) and NFI (Deneen
et al., 2006) both repress neurogenesis at the same time
that they promote gliogenesis, but we don’t have a de-
tailed understanding of how this happens. Such informa-
tion is important, not only with regard to development,
but also with regard to the adult nervous system. For ex-
ample, why do adult precursors from the SVZ and in the
hippocampus make neurons, even though transplant
studies have shown us that the adult CNS is a gliogenic
environment? Would such information allow us to
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ReviewTable 1. Molecular Perturbations that Lead to Premature Astrocyte Formation In Vivo
Gene Reference Manipulation and Phenotype
Growth factors, growth factor receptors, and signaling pathways
ErbB2 Schmid et al., 2003 Inhibition of ErbB2 in radial glia and astrocytes in transgenic mice
by expression of a dominant-negative ErbB2 from the human
gfap promoter led to appearance of astrocytes in the cortex
by E16.
ErbB4 Sardi et al., 2006 Analysis of erbB4/ mice in which the heart defect was rescued
demonstrated robust astrocyte formation in the cortex by E17.5.
EGFR Burrows et al., 1997 Overexpression of EGFR in E12 rat cortical explants led to
premature appearance of S100b+, GFAP+ astrocytes 4 days later
(equivalent to E16).
CNTF Barnabe´-Heider et al., 2005 Ectopic expression of CNTF in cortical precursors at E13.5 using
in utero electroporation led to the appearance of GFAP+, S100b+
astrocytes in the cortex by E16
SHP-2 Gauthier et al., 2007 Genetic knockdown of SHP-2 in cortical precursors at E13/14
caused premature formation of GFAP+ astrocytes
at E16/17.
Transcriptional regulators
Dnmt1 Fan et al., 2005 Conditional ablation of dnmt1 in neural precursors, achieved by
crossing nestin:Cre mice with floxed dnmt1 mice, led to
premature appearance of GFAP+ cells in the spinal cord as early
as E12, and in the cortex, by E18.
N-CoR Hermanson et al., 2002 Analysis of n-cor/ mice demonstrated robust premature
astrogenesis by E15.5 in the developing neocortex of more than
70% of the knockout mice.
Neurogenic bHLHs Tomita et al., 2000; Nieto et al., 2001 Analysis of mash1/;math3/ double mutant mice revealed
premature astrocyte formation within both the midbrain and
hindbrain by E15.5. Analysis of the cortex of mash1/;ngn2/
embryos demonstrated the presence of RC2+ cells with
astrocyte morphology at E15.5 in all mice, and premature GFAP+
astrocytes at E18.5 in one of three embryos.
Olig bHLHs Zhou and Anderson, 2002 Analysis of olig1/;olig2/ double mutant embryos revealed
ectopic astrocytes within the embryonic spinal cord.
Id1 Cai et al., 2000 Overexpression of Id1 in cortical precursors at E12 using
retroviruses in vivo led to premature genesis of cells with glial
morphology by E16.
NFIA/B Deneen et al., 2006 Overexpression of NFIA/B in embryonic chick spinal cord
precursors caused premature induction of cells expressing both
early and late astrocyte markers.
Scl Muroyama et al., 2005 Overexpression of scl in embryonic chick spinal cord precursors
caused appearance of ectopic early astrocytes.manipulate the environment of the mature, injured CNS to
promote neurogenesis rather than gliogenesis?
A second key question is how intrinsic changes in pre-
cursor cell responsiveness might be regulated by environ-
mental cues. Several potential mechanisms are sug-
gested by studies in other cell types. In epithelial cells,
MEK can induce selective promoter methylation by
dnmt3 (Pruitt et al., 2005) suggesting that one way that
the MEK-ERK-C/EBP pathway might repress gliogenesis
is by causing methylation of astrocyte genes. Moreover,
STAT3 itself can directly form a complex with dnmt1(Zhang et al., 2005), suggesting that the gliogenic JAK-
STAT pathway may also directly regulate epigenetic si-
lencing in the developing nervous system. Finally, the
methyl-CpG-binding protein 2 (MeCP2), which binds to
methylated CpG dinucleotides and modifies chromatin
structure, was recently shown to be phosphorylated in re-
sponse to Ca2+ influx in neurons (Zhou et al., 2006). Since
MeCP2 is mutated in a variety of neurodevelopmental dis-
orders, including Rett syndrome (Moretti and Zoghbi,
2006), and since it binds to the promoters of glial genes
in early precursors (Namihira et al., 2004; Fan et al.,Neuron 54, May 3, 2007 ª2007 Elsevier Inc. 365
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transmitter or growth factor receptor activation could
directly regulate chromatin structure. Thus, there are mul-
tiple ways that the environment could regulate the ‘‘intrin-
sic’’ changes seen in cortical precursors, and a key issue
is what, if any, role these play in regulating the gliogenic
timing mechanism.
A third and final question for the future is whether pertur-
bations of the neurogenic-to-gliogenic timer play any role
in neurodevelopmental disorders that result in cognitive
dysfunction or mental retardation. One would imagine
that alterations in the timing and/or numbers of different
cells that were generated during embryogenesis would
have a profound impact on the subsequent establishment
and function of neural circuitry. Support for this idea
comes from a recent study demonstrating that enhanced
activation of SHP-2 in a mouse model of Noonan syn-
drome, a human genetic disorder where one-third to
one-half of affected individuals have learning disabilities
or mental retardation, caused perturbations in cortical
cell fate genesis (Gauthier et al., 2007). Interestingly, the
neurogenic SHP-2-Ras-MEK-ERK pathway is also in-
volved in the related genetic disorders Costello syndrome
and cardio-facial-cutaneous syndrome, both of which dis-
play mental retardation as part of their phenotype (re-
viewed in Bentires-Alj et al., 2006).Moreover, even hetero-
zygosity for a loss-of-function allele of the coactivator
CBP, which as discussed above is a key integrator of mul-
tiple neurogenic and gliogenic transcription factors, is suf-
ficient to cause mental retardation in Rubinstein-Taybi
syndrome (Josselyn, 2005). All of these genetic perturba-
tions would be predicted, by the studies reviewed here, to
alter cell fate genesis in the embryonic nervous system,
and to thereby set the stage for a miswired and dysfunc-
tional CNS. However, with the exception of the Noonan
syndromemouse, we still don’t know whether such devel-
opmental dysgenesis actually occurs, and/or its relative
importance for the development of human cognitive dys-
function. Addressing this and the other key issues raised
here will provide us with insights into both normal and ab-
errant development andmay also help us to recruit endog-
enous and exogenous neural stem cells to repair the in-
jured or degenerating nervous system.
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